Institutional Ownership
Nanobiotix
CUSIP 63009J107SPONSORED ADSNBTXQ1 2026
13D / 13G Filings
15
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
11.9%
Max % of class reported
Institutional Holders
15
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
15 filings · latest Apr 17, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Apr 17, 2025 | Invus Public Equities, L.P. | 13G | 8.9% | 4.23M | SEC |
| 2 | Feb 12, 2025 | Baillie Gifford &Amp; Co | 13G/A | 4.1% | 1.92M | SEC |
| 3 | Feb 9, 2024 | Artal International S.C.A. | 13G/A | — | — | SEC |
| 4 | Feb 8, 2024 | Qatar Investment Authority | 13G/A | 9.1% | 4.30M | SEC |
| 5 | Feb 2, 2024 | Johnson & Johnson | 13G/A | 11.9% | 5.62M | SEC |
| 6 | Jan 29, 2024 | Baillie Gifford & Co | 13G/A | 6.2% | 2.87M | SEC |
| 7 | Nov 16, 2023 | Johnson & Johnson Innovation - Jjdc, Inc. | 13G | 10.2% | 4.72M | SEC |
| 8 | Nov 8, 2023 | Qatar Investment Authority | 13G | 8.6% | 3.83M | SEC |
| 9 | Feb 2, 2023 | Baillie Gifford & Co | 13G/A | 4.3% | 1.51M | SEC |
| 10 | Jan 20, 2023 | Baillie Gifford & Co | 13G/A | 5.0% | 1.74M | SEC |
5 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Nanobiotix.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Johnson & Johnson | 5.62M | $173.61M |
| 2 | Morgan Stanley | 36.3K | $1.12M |
| 3 | Optiver Holding B.V. | 13.5K | $416.8K |
| 4 | Marshall Wace, LLP | 9.2K | $285.2K |
| 5 | Ubs Group AG | 5.6K | $171.5K |
| 6 | Bnp Paribas Financial Markets | 3.6K | $109.9K |
| 7 | Rhumbline Advisers | 2.3K | $70.4K |
| 8 | Royal Bank Of Canada | 1.8K | $56.0K |
| 9 | Gamma Investing LLC | 828 | $25.6K |
| 10 | Eversource Wealth Advisors, LLC | 514 | $15.9K |